NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 73 filers reported holding NEOS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $26,000 | +100.0% | 41,401 | +71.1% | 0.00% | +50.0% |
| Q3 2020 | $13,000 | -69.0% | 24,197 | -13.0% | 0.00% | -50.0% |
| Q4 2019 | $42,000 | +68.0% | 27,813 | +41.1% | 0.00% | +300.0% |
| Q2 2019 | $25,000 | -80.9% | 19,705 | -60.9% | 0.00% | -85.7% |
| Q1 2019 | $131,000 | -27.6% | 50,422 | +131.5% | 0.01% | -30.0% |
| Q1 2018 | $181,000 | -32.5% | 21,779 | -17.1% | 0.01% | -28.6% |
| Q4 2017 | $268,000 | – | 26,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|